COVID-19 第一波疫情对哮喘吸入器处方的影响。
Influence of the first wave of COVID-19 on asthma inhaler prescriptions.
机构信息
National Heart and Lung Institute, Imperial College London, Guy Scadding Building, Dovehouse Street, London, SW3 6LY, UK.
Imperial College Healthcare NHS Trust and Imperial College London, NHLI, London, UK.
出版信息
NPJ Prim Care Respir Med. 2021 Nov 25;31(1):45. doi: 10.1038/s41533-021-00260-w.
In the beginning of the COVID-19 pandemic, there were major concerns regarding the huge demand for asthma inhalers. Using the primary-care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantial increase in inhalers solely in March 2020. Patients significantly associated with receiving higher inhaled corticosteroid prescriptions were younger, of higher socioeconomic status, and had milder asthma.
在 COVID-19 大流行初期，人们主要担心对哮喘吸入器的巨大需求。我们使用了 2020 年 1 月至 6 月期间 614700 名哮喘患者的初级保健医疗记录，发现仅在 2020 年 3 月，吸入器的使用量就大幅增加。明显与接受更高剂量吸入皮质类固醇处方相关的患者更年轻，社会经济地位更高，且哮喘程度较轻。
Zotero 插件